NCT03872388
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy treatment 2 terminated NCT04314401
National Cancer Institute "Cancer Moonshot Biobank" No drug interventions Not Available Not Available recruiting NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV treatment 1 active_not_recruiting NCT05049746
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy No drug interventions supportive_care Not Available recruiting NCT05092373
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax treatment 1 recruiting NCT05327608
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery No drug interventions supportive_care Not Available suspended NCT05422794
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer treatment 1 suspended NCT05564377
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial screening 2 recruiting NCT05741164
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer treatment 2 not_yet_recruiting NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab treatment 3 recruiting NCT06042569
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial treatment 2 recruiting NCT06058377
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer treatment 3 recruiting NCT06534125
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study No drug interventions supportive_care Not Available recruiting NCT04704661
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial treatment 1 recruiting NCT05025059
Exercise During Chemotherapy in Older Women with Stage I-III Breast Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT05183828
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer treatment 4 recruiting NCT05547347
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients with Locally Advanced Breast Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT05595499
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors treatment 2 recruiting NCT05874297
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT05930483
Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors No drug interventions prevention Not Available not_yet_recruiting NCT06179303
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer treatment 2 suspended NCT06392789
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors No drug interventions treatment Not Available recruiting NCT06401889
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy No drug interventions Not Available Not Available recruiting NCT06590558
Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer treatment 1 not_yet_recruiting NCT06617455
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial supportive_care 2 not_yet_recruiting NCT06434064
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer treatment 2 not_yet_recruiting NCT05677802
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer No drug interventions health_services_research Not Available recruiting NCT05967533
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors No drug interventions treatment 1 recruiting NCT03630354
EXERCISING TOGETHER for Couples Coping With Cancer No drug interventions supportive_care Not Available completed NCT05379153
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial No drug interventions supportive_care 3 not_yet_recruiting NCT01149083
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer treatment 2 active_not_recruiting NCT05710328
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial No drug interventions diagnostic 2 recruiting NCT04139993
RBX7455 Before Surgery for the Treatment of Operable Breast Cancer No drug interventions treatment 1 terminated NCT04876378
Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand No drug interventions Not Available Not Available terminated NCT05674578
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT05243056
A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer No drug interventions supportive_care Not Available recruiting NCT03941756
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma prevention Not Available recruiting NCT04862585
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel supportive_care 2 / 3 completed NCT05673200
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer treatment 1 suspended NCT04927559
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy No drug interventions Not Available Not Available terminated NCT06193070
An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information No drug interventions supportive_care Not Available completed NCT03725436
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors treatment 1 active_not_recruiting NCT04345913
Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer treatment 1 / 2 active_not_recruiting NCT03666819
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy No drug interventions treatment 2 withdrawn NCT05244434
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer No drug interventions basic_science Not Available withdrawn NCT06113016
Prevention of Frailty With Fisetin and Exercise (PROFFi) in Breast Cancer Survivors supportive_care 2 recruiting NCT05455658
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer prevention 2 recruiting NCT05967286
Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment Trial treatment 2 withdrawn NCT04454086
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT04560439
Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors No drug interventions other Not Available withdrawn NCT04249622
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer treatment 2 active_not_recruiting NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer No drug interventions supportive_care Not Available terminated NCT05928325
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment No drug interventions supportive_care Not Available recruiting NCT04999826
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors No drug interventions Not Available Not Available active_not_recruiting NCT05539365
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer treatment 2 not_yet_recruiting NCT04329065
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer treatment 2 recruiting NCT02918474
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer No drug interventions supportive_care Not Available recruiting NCT04498520
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer treatment 1 withdrawn NCT02453620
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer treatment 1 active_not_recruiting NCT04200482
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors No drug interventions supportive_care 2 completed NCT02115282
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic treatment 3 active_not_recruiting NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer treatment 1 / 2 recruiting NCT05012176
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer supportive_care 2 active_not_recruiting NCT04090567
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer treatment 2 recruiting NCT03132467
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer treatment 0 completed NCT03620201
M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer treatment 1 active_not_recruiting NCT03774472
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer treatment 1 / 2 completed NCT04216472
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations treatment 2 active_not_recruiting NCT04754412
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study No drug interventions supportive_care Not Available recruiting NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT05452681
A QoL Intervention for Young African American Breast Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT03523195
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT05417308
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer treatment 0 recruiting NCT04693338
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer No drug interventions supportive_care 1 completed NCT03291938
IACS-010759 in Advanced Cancers No drug interventions treatment 1 completed NCT04205903
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer treatment 1 recruiting NCT05945290
Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer No drug interventions Not Available Not Available recruiting NCT05786664
Breast Cancer Survivorship Biorepository No drug interventions Not Available Not Available recruiting NCT01334021
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer No drug interventions diagnostic 2 active_not_recruiting NCT03786354
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer No drug interventions treatment Not Available active_not_recruiting NCT05412953
Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain No drug interventions supportive_care Not Available completed NCT05071677
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer No drug interventions Not Available Not Available completed NCT03106077
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer treatment 2 completed NCT04857697
Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer supportive_care 0 completed NCT04835597
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy No drug interventions Not Available Not Available terminated NCT05368428
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer No drug interventions supportive_care Not Available recruiting NCT03505671
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer No drug interventions supportive_care Not Available completed NCT04549571
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions No drug interventions health_services_research Not Available recruiting NCT04205071
Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer treatment 1 withdrawn NCT06582615
Food for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer No drug interventions supportive_care Not Available recruiting NCT04906200
Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT03715959
Nipple Aspirate Fluid in Detecting Breast Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT04086875
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04379570
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy No drug interventions health_services_research 3 recruiting NCT04491942
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer treatment 1 active_not_recruiting NCT03518242
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer treatment 1 completed NCT03751449
Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors No drug interventions supportive_care Not Available terminated NCT03505736
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer Not Available Not Available completed NCT04443413
Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients No drug interventions treatment 3 recruiting NCT05177796
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer treatment 2 withdrawn NCT04457596
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial treatment 3 recruiting NCT02849496
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer treatment 2 active_not_recruiting NCT04715958
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer diagnostic 2 / 3 recruiting NCT06238986
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy No drug interventions Not Available Not Available recruiting NCT06016725
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial No drug interventions supportive_care Not Available recruiting NCT04294225
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer treatment 2 completed NCT03941730
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer treatment 2 active_not_recruiting NCT04673448
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 recruiting NCT03218826
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study No drug interventions Not Available Not Available active_not_recruiting NCT04716920
Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial No drug interventions supportive_care Not Available completed NCT06106282
Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) No drug interventions Not Available Not Available recruiting NCT05238831
SMMART Adaptive Clinical Treatment (ACT) Trial treatment 0 withdrawn NCT05086731
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer No drug interventions screening 0 completed NCT04550494
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations treatment 2 recruiting NCT03207529
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer treatment 1 completed NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer treatment 1 active_not_recruiting NCT06324240
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer treatment 1 not_yet_recruiting NCT04249167
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer treatment 0 withdrawn NCT03179904
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer treatment 2 active_not_recruiting NCT05568472
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study No drug interventions supportive_care Not Available recruiting NCT05464810
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer treatment 0 recruiting NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04862195
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment No drug interventions treatment Not Available terminated NCT04678414
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer No drug interventions Not Available Not Available recruiting NCT00507923
Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer No drug interventions supportive_care Not Available completed NCT04535323
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer supportive_care 1 completed NCT03979508
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer treatment 2 recruiting NCT04959474
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer No drug interventions supportive_care Not Available recruiting